We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current IMR market cap is 259.68M. The company's latest EPS is USD -0.1202 and P/E is -11.65.
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 640k | 702k | 696k | 816k | 616k |
| Operating Income | -6.55M | -11.98M | -20.26M | -17.26M | -16.86M |
| Net Income | -13.29M | -12.45M | -19.73M | -17.36M | -22.63M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 10.52M | 33.57M | 26.86M | 13.7M | 8.31M |
| Total Liabilities | 3.49M | 4.75M | 4.46M | 6.19M | 17.06M |
| Total Equity | 7.03M | 28.82M | 22.4M | 7.51M | -8.75M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -6.63M | -12.23M | -17.49M | -16.51M | -12.98M |
| Investing | -529k | -774k | -695k | -239k | -83k |
| Financing | 10.45M | 33.03M | 11.59M | 3.94M | 8.21M |
| Market Cap | 259.68M |
| Price to Earnings Ratio | -11.65 |
| Price to Sales Ratio | 424.24 |
| Price to Cash Ratio | 318.18 |
| Price to Book Ratio | -30.1 |
| Dividend Yield | - |
| Shares Outstanding | 188.17M |
| Average Volume (1 week) | 293.81k |
| Average Volume (1 Month) | 305.53k |
| 52 Week Change | 176.00% |
| 52 Week High | 1.70 |
| 52 Week Low | 0.41 |
| Spread (Intraday) | 0.03 (1.78%) |
| Company Name | Imricor Medical Systems Inc |
| Address |
850 new burton road suite 201 wilmington, delaware 19904 |
| Website | https://imricor.com |
| Industry | med, dental, hosp eq-whsl (5047) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
